Earnings Call · Q2 FY2021·2021-08-05

Q2 21EPS -3.92%·Rev n/aQ1 21EPS -4.08%·Rev n/aQ4 20EPS -6.82%·Rev n/aQ3 20EPS +13.04%·Rev n/a⚠ consensus missing

IOVANCE BIOTHERAPEUTICS, INC. IOVA

Sara Pellegrino — Unknown

Frederick Vogt — Interim President and Chief Executive Officer

Igor Bilinsky — Chief Operating Officer

Jim Zigler — Senior Vice President, Commercial

Friedrich Finckenstein — Chief Medical Officer

Jean-Marc Bellemin — Unknown (likely Chief Financial Officer or similar finance role)

−1.6%1d on move date−1.8% vs SPY3d−2.8%5d−7.5%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IOVA calls or request research access.

More IOVA calls Browse calls Request research access